m+Medelevator.RU
← Поиск публикаций
Asia-Pacific journal of oncology nursing · 2015

Factors affecting the quality of life of cancer patients undergoing chemotherapy: A questionnaire study.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Üstündağ S, Zencirci AD

Аннотация

ObjectiveThis descriptive and cross-sectional study was undertaken to determine the factors affecting cancer patients' quality of life.MethodsWe collected data from 352 chemotherapy patients of an Outpatient Chemotherapy Unit in a state hospital. We included volunteered chemotherapy patients with a signed informed consent and at least 50 Karnofsky Performance Scale points. We gathered data by Personal Information Form and Nightingale Symptom Assessment Scale (N-SAS) and analyzed via basic descriptive statistics and linear regression analysis.ResultsPatients were women (54.8%), married (83.5%), elementary school graduates (57.1%), housewives (44.6%) and undergoing fluorouracil-based therapy (47.2%), and almost all patients had religious and cultural rituals for the disease. Women experienced worse physical and social well-being than men (P = 0.001, P = 0.0001). Singles had worse psychological and general well-being (P = 0.0001, P = 0.0001). Housewives had the worst physical and social well-being (P P > 0.05). Breast cancer and sarcoma patients had the worst social well-being than other cancer patients. The N-SAS points of patients were not affected by blessings/prays, vow/sacrifice, consulting local herbalists and visiting "ocaks (folk physicians)" (P > 0.05). Patients with bad quality of life practiced lead pouring and amulets (P ConclusionAdvanced studies on individual quality of life factors affecting cancer would empower nurses for better personal care techniques and patients for easily overcoming the disease.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Introduction

Cancer, faced every day, is second to heart disease as a cause of death. One-fourth of the deaths in the USA were because of cancer; daily 1600 Americans[ 1 ] and 1.75 millions of Europeans in 2012.[ 2 ]

Cancer patients face some psychological problems — stress, anxiety, depression; some physiological side-effects — hair loss, pain, tiredness, nausea, vomiting; some social side-effects — social isolation, role and function loss; and, eventually, a worsened quality of life.[ 3 , 4 , 5 ]

The purpose of cancer therapy is not only to cure the cancer and increase the survival but also to minimize the symptoms and alleviate the quality of life. In other words, better quality of life increases patients’ adaptation and desire for the therapy. Higher quality of life leads patients to complete therapy with the lowest harm, control experienced symptoms and overcome these symptoms.[ 6 ]

Quality of life is an individuals’ perception of their aims, expectations, interests and ideas, satisfaction and happiness among their cultural and values as a whole.[ 7 ] Quality of life is the effect of patients’ physical (movement, physical activities and ability to succeed in work and in family responsibilities), social (social activities, being beneficial, body image, anxiety and depression) and psychological (life satisfaction, social support need and role function) for well-being. Symptoms of disease and therapy are pain, respiration difficulty, nausea, alopecia, impotence and, of course, side-effects of the same.[ 8 , 9 ]

Many factors affect quality of life positively or negatively. Tiredness, anxiety, concern for the future and the family, difficulties to meet basic demands and changes in body image worsen the quality of life of cancer patients.[ 3 , 5 ] Social support, economic security and faith in recovery improve the quality of life.[ 10 , 11 , 12 ]

Cancer patients make use of complementary therapies in order to improve their qualities of life. Cancer and chemotherapy worsen quality of life and increase the need for complementary therapy.[ 13 ] Patients with lower quality of life prefer more complementary therapy.[ 14 , 15 ] The religion, beliefs and cultural rituals may interact with each other and crises faced increase religious practices.[ 16 ] Religious and spiritual practices improve quality of life, physical well-being, hope and general life satisfaction, and diminish anxiety.[ 17 , 18 ] Religion, a factor to overcome the disease, is related to socio-cultural and economic characteristics of individuals.[ 19 ] Further studies on cancer factors affecting quality of life of patients would allocate oncology nurses better personal care techniques in order to help those cancer patients effectively.

We carried out this study in order to determine the factors affecting the quality of life of cancer patients. The research questions were:

Is there any relationship between socio-demographic characteristics of cancer patients and their N-SAS points?

Is there any relationship between medical characteristics of cancer patients and their N-SAS points?

Is there any relationship between N-SAS points of patients with complementary/religious therapies and without?

Is there any relationship between gender and their N-SAS points?

Materials and methods

Study design and sample

We implemented this descriptive cross-sectional study in the Daytime Chemotherapy Unit (for patients ≤18 years of age) of the College District Outpatients in the Ankara Numune Training and Research Hospital. The universe of the study was 526 patients undergoing chemotherapy in the Daytime Chemotherapy Unit during January–June 2013. We did not sample, but excluded some patients – those rejected to participate ( n = 58) at the beginning, stopped participating during the study ( n = 62) because of tiredness, nausea, vomiting and pain etc. had lower than 50 Karnofsky Performance Scale (KPS) point ( n = 9) and took just the first chemotherapy ( n = 45). Therefore, we only reached 352 of the patients, and a response rate of 66.9%.

Ethical considerations

We obtained ethical permission from the Ankara University Ethics Board (numbered 589 and dated September 27 th , 2012) for the study. We acquired another permission (numbered 85346189/1426 and dated January 9 th , 2013) from the Ankara Numune Training and Research Hospital through the First General Secretariat of Turkish Public Hospitals Foundation, in order to apply the study there. We also obtained informed consents from the patients after explaining the study to them clearly.

Inclusion criteria

We included chemotherapy taking volunteering patients with at least 50 Karnofsky Performance Scale points and with an informed consent form signed. We included patients with cancer diagnosis and chemotherapy cure without differentiating the cancer type.

Pilot trial and data collection

The pilot study was performed on 30 individuals who were excluded from the research and the questionnaire was then modified based on the pilot study. We collected data from 352 patients during January–June 2013. We filled out the questionnaires via face to face interviews after obtaining informed consents. The average time for each questionnaire was 20 min. We directly asked the patients about their demographic backgrounds, cancer history and complementary therapy. Information on diagnosis, phase and chemotherapy taken were, however, composed from medical files. We preferred the word “the disease” in the surveys in case patients as they did not know whether they had “cancer” or not yet. Patients, if literate, filled out the Nightingale Symptom Assessment Scale (N-SAS), which measures the quality of life of patients. If illiterate, we read and recorded the answers.

Instruments

Questionnaires were two part: Demographic data in the first part and N-SAS in the second part.[ 20 ] We determined the suitability of patients for the study by checking for the KPS[ 21 ] before the application of the questionnaire.

Personal information form

This first part contained patient information. We ourselves prepared the form, based on the literature.[ 22 , 23 , 24 , 25 , 26 ] It contained age, gender, data on disease and geographic origin. Moreover, information on whether anyone in the family was diagnosed as having cancer, its degree and complementary therapy and cultural/religious rituals practiced was collected by open-ended questions. We grouped open-ended questions before the evaluation.

N-SAS

We used the N-SAS to evaluate patients’ quality of life. The N-SAS is a quality of life scale for cancer patients. It has 38 items and three sub-scales: Physical well-being (PhWB; 1-4 th , 6-15 th , 23-27 th and 37 th item), social well-being (SoWB; 5 th and 16-22 nd items) and psychological well-being (PsWB; 28-36 th and 38 th items). Each item in the scale expressed the degree of the influence from each problem while the scale and sub-scales reflected the quality of life. This Likert type (0-4) scale assess answers from 0 (none) to 4 (too much). The higher values indicate the higher problems faced during the therapy.[ 20 ]

Sub-scale points were calculated by dividing summed points of all items by item numbers and general scale points by dividing summed points of all sub-scales by three. No answer existed for some questions (i.e., the effect of disease on sexual life in singles/divorced/widows). Higher points in sub-scales indicated lower well-being for general or special sub-scale goodness.

Life quality points between 0 and 0.50 meant “very good,” between 0.51 and 1.50 meant “good,” between 1.51 and 2.50 meant “moderate,” between 2.51 and 3.50 meant “bad” and between 3.51 and 4.00 meant “very bad.” Cronbach alfa values of the scale were PhWB α = 0.81, SoWB α = 0.87 and PsWB α = 0.9.[ 27 ] We calculated the PhWB α = 0.822, SoWB α = 0.697 and PsWB α = 0.862 for the sub-scales. General well-being α, calculated on overall N-SAS, was 0.888.

Statistical analysis

Data, after being coded, were analyzed by SPSS (Statistical package for social sciences for windows 16.0). We used the significance test for differences between two means and the Mann–Whitney U test for heterogeneous data; one-way analysis of variance for multiple groups and the Tukey HSD test for group comparisons. We also ran linear regression for each gender separately[ 28 ] in order to determine the main variable affecting the quality of life.

Results

Women experienced worse PhWB and SoWB than men ( t = 3.285, P = 0.001; Z = 4.529, P = 0.0001). Singles had worse PsWB and general well-being than married patients ( t = 14.294, P = 0.0001; t = 13.783, P = 0.0001). There was no relationship between education and quality of life ( P > 0.05). Housewives had lower PhWB and SoWB than other groups that were studied ( P < 0.05). Government clerks had worse PsWB and general well-being than the other groups in the study ( P = 0.0001) [ Table 1 ].

Table 1
Comparison of patients’ socio-demographic values and N-SAS points ( n = 352)
a: Student t test was applied, b: Mann-Whitney U test was applied because of heterogeneity, c: One-way analysis of variance was applied, d: Kruskal–Wallis test was applied because of heterogeneity, e: Tukey test was applied

Descriptive characteristicsnN-SAS points
PhWBSoWBPsWBGeneral well-being
Mean ± SDMean ± SDMean ± SDMean ± SD
Gender
Female1930.070±0.030.021±0.010.128±0.270.220±0.27
Male1590.059±0.020.013±0.010.098±0.230.172±0.23
t =3.285 aZ =4.529 bt =1.093 at =1.759 a
P =0.001P =0.0001P =0.275P =0.079
Marital status
Married2940.065±0.030.018±0.010.046±0.020.130±0.05
Single580.063±0.030.014±0.010.465±0.500.543±0.50
t =0.497 at =1.862 at =14.294 at =13.783 a
P =0.619P =0.063P =0.0001P =0.0001
Education
Illiterate410.075±0.030.024±0.010.119±0.250.216±0.25
Elementary2010.065±0.030.018±0.010.096±0.210.179±0.22
Secondary330.058±0.030.014±0.010.094±0.230.167±0.24
High school460.060±0.030.019±0.010.159±0.330.239±0.31
University310.064±0.030.015±0.010.190±0.360.270±0.37
F =1.690 cF =1.228 cF =1.354 cF =1.324 c
P =0.152P =0.299P =0.250P =0.261
Occupation
Farmer120.053±0.030.012±0.060.033±0.020.098±0.04
Housewife1570.073±0.030.022±0.010.120±0.250.215±0.25
Retired590.062±0.030.016±0.010.051±0.120.130±0.13
Temporary (Free lance)570.055±0.030.013±0.010.137±0.290.206±0.29
Clerk320.065±0.030.014±0.010.160±0.320.240±0.32
Labor350.056±0.020.013±0.010.149±0.310.219±0.31
F =4.281 cF =5.301 cχ 2= 15.747 dχ 2= 21.254 d
P =0.001 eP =0.0001 eP =0.003P =0.0001

Patients who were operated first and then took radiotherapy and chemotherapy had lower ( F = 4.820, P = 0.0009) SoWB than others. Breast, sarcoma and head/neck cancer patients had worse life qualities. Similarly, patients under Taxane therapies had lower SoWB values (χ 2 = 29.134, P = 0.0001) [ Table 2 ].

Table 2
Comparison of patients’ medical characteristics and N-SAS points ( n = 352)
a: One-way ANOVA was applied, b: Tukey test was applied, c: Kruskal–Wallis test was applied because of heterogeneity

Medical characteristicsnN-SAS points
PhWBSoWBPsWBGeneral well-being
Mean ± SDMean ± SDMean ± SDMean ± SD
Therapy history
Only chemotherapy1280.063±0.030.016±0.010.129±0.280.209±0.28
Operation+chemotherapy1250.063±0.020.016±0.010.113±0.240.193±0.25
Operation+radiotherapy+chemotherapy990.070±0.030.021±0.010.098±0.230.191±0.23
F =1.616 aF =4.820 aF =0.401 aF =0.181 a
P =0.200P =0.009P =0.670P =0.834
Chemotherapy cure take
2 nd cure1090.059±0.030.013±0.010.119±0.260.191±0.26
3 rd cure1100.063±0.030.018±0.010.122±0.260.203±0.26
4 th cure460.076±0.030.024±0.010.085±0.190.185±0.20
5 th cure280.061±0.030.019±0.010.175±0.340.255±0.33
6 th cure380.076±0.030.021±0.010.043±0.030.141±0.06
7 th cure210.069±0.020.021±0.010.172±0.340.263±0.35
F =3.129 aF =4.749 aχ 2 =1.092 cχ 2 =6.873 c
P =0.009 bP =0.0001 bP =0.955P =0.230
Diagnosis
Lung cancer240.061±0.030.013±0.010.163±0.320.238±0.32
Colorectal cancer710.060±0.030.012±0.0090.132±0.290.205±0.28
Lymphoma170.056±0.020.017±0.010.098±0.230.172±0.25
Breast cancer800.072±0.030.026±0.010.069±0.150.167±0.16
Gynecologic cancer50.076±0.010.021±0.0060.058±0.010.156±0.01
Sarcoma120.069±0.030.022±0.010.024±0.020.115±0.05
Gastrointestinal cancer790.062±0.030.015±0.010.102±0.230.181±0.24
Head neck cancers80.070±0.030.025±0.010.159±0.340.255±0.34
Urinary cancers270.058±0.020.016±0.010.151±0.300.226±0.29
Multiple myeloma90.067±0.030.013±0.0070.030±0.020.111±0.04
Hematologic malignity200.079±0.030.019±0.010.282±0.420.381±0.41
F =1.429 aχ 2 =37.860 cχ 2 =13.886 cχ 2 =14.779 c
P =0.166P =0.001P =0.178P =0.140
Chemotherapy types taken
Platinum based510.064±0.020.017±0.010.102±0.220.184±0.23
Fluorouracil based1660.063±0.030.013±0.010.137±0.290.214±0.29
Taxane based590.071±0.020.025±0.010.109±0.240.207±0.24
Doxorubicin based400.062±0.030.020±0.010.037±0.020.120±0.06
Targeted therapy360.067±0.030.021±0.010.126±0.260.215±0.26
F =0.775 aχ 2= 29.134 cχ 2 =5.812 cχ 2 =7.754 c
P =0.542P =0.0001P =0.214P =0.101

Blessings or prayers, vow or sacrifice or consulting local herbalists did not affect the N-SAS points ( P > 0.05). Lead pouring patients had worse quality of life for PhWB and SoWB than no lead pouring ones ( t = 2.735, P = 0.007; t = 2.964, P = 0.003). Visiting religious people (Hodja or Ocak) did not influence the N-SAS points ( P > 0.05). Tomb visitors had worse quality of life for SoWB than non-tomb visitors ( t = 2.363, P = 0.019) [ Table 3 ]. Amulet use and holy water drinking did not change patients’ N-SAS points ( P > 0.05). Charm use patients, on the other hand, had worse SoWB than non-charm users ( t = 3.582, P = 0.0001). Patients’ religious and cultural rituals for well-being did not affect the quality of life ( P > 0.05) [ Table 3 ].

Table 3
Comparison of patients’ religious and cultural rituals and N-SAS points ( n = 352)
a: Student’s t test was applied, b: Mann–Whitney U was applied because of heterogeneity, c: Folk physician

Religious and cultural ritualsnN-SAS points
PhWBSoWBPsWBGeneral well-being
Mean ± SDMean ± SDMean ± SDMean ± SD
Any complementary therapy
Yes1280.068±0.030.019±0.010.118±0.250.206±0.26
No2240.063±0.030.017±0.010.113±0.250.194±0.25
t =1.526 at =1.575 aZ =0.735 cZ =1.439 c
P =0.128P =0.116P =0.462P =0.150
Blessings/prayers
Yes3210.066±0.030.018±0.010.116±0.250.200±0.26
No310.059±0.030.013±0.010.102±0.240.175±0.24
t =1.124 at =1.688 at =0.300 at =0.531 a
P =0.262P =0.092P =0.765P =0.595
Vow/sacrifice
Yes800.063±0.030.021±0.010.135±0.290.220±0.29
No2720.066±0.030.017±0.010.109±0.240.192±0.24
t =0.692 at =2.370 at =0.796 at =0.841 a
P =0.490P =0.018P =0.427P =0.401
Consult local herbalist
Yes560.066±0.030.021±0.010.159±0.320.246±0.32
No2960.065±0.030.017±0.010.106±0.240.189±0.24
t =0.218 at =1.677 aZ=0.125 bZ=1.059 b
P =0.828P =0.094P =0.900P =0.290
Lead pouring
Yes130.088±0.020.029±0.010.116±0.260.235±0.24
No3390.064±0.030.017±0.010.115±0.250.197±0.25
t =2.735t =2.964Z=0.125 bZ=1.059 b
P =0.007P =0.003P =0.900P =0.290
Consult religion person/Hodja
Yes70.069±0.040.025±0.010.034±0.020.129±0.06
No3450.065±0.030.017±0.010.116±0.250.200±0.26
t =0.299 bt =1.355t =0.836t =0.715
P =0.765P =0.176P =0.404P =0.404
Visit Ocak c
Yes50.091±0.030.019±0.0040.028±0.030.139±0.04
No3470.065±0.030.018±0.010.116±0.250.199±0.26
t =1.865 bt =0.201 bt =0.758 bt =0.514 b
P =0.063P =0.841P =0.449P =0.608
Visit tomb
Yes230.072±0.030.025±0.010.043±0.020.141±0.51
No3290.025±0.010.017±0.010.120±0.260.202±0.26
t =1.050 at =2.363 aZ=0.316 bZ=0.617 b
P =0.295P =0.019P =0.752P =0.537
Amulet
Yes60.075±0.040.019±0.010.188±0.390.283±0.38
No3460.065±0.030.018±0.010.113±0.250.197±0.25
t =0.769 at =0.236 at =0.704 at =0.806 a
P =0.442P =0.814P =0.482P =0.421
Drink holy waters (zem zem)
Yes480.069±0.030.020±0.010.059±0.140.148±0.14
No3040.064±0.030.017±0.010.124±0.260.206±0.27
t =0.881 at =1.184 aZ=1.453 bZ=0.632 b
P =0.379P =0.237P =0.146P =0.527
Charm
Yes90.084±0.020.035±0.010.128±0.320.248±0.31
No3430.065±0.030.017±0.010.114±0.250.197±0.25
t =1.881 at =3.582 at =0.158 at =0.589 a
P =0.061P =0.0001P =0.875P =0.556

Some independent factors affected the quality of life and resulted in some regression models [ Table 4 ]. A higher number of chemotherapy sessions worsened PhWB, singleness PsWB and marriage general well-being in women. Furthermore, a non-permanent job improved PhWB; fluorouracil therapy, 2 nd chemotherapy and urinary cancer enhanced SoWB; and retired patients and farmers and those with multiple myeloma had improved general well-being and, therefore, better quality of life [ Table 4 ]. In men, 6th cure of chemotherapy worsened SoWB; urinary cancer, student, taxane cure and lymphoma worsened SoWB; and singleness worsened general well-being and, therefore, quality of life. Furthermore, 2 nd chemotherapy worsened SoWB; married, sarcoma and studentship worsened PsWB; and sarcoma and studentship improved general well-being, and therefore, quality of life [ Table 4 ].

Table 4
Linear regression between quality of life and gender

GenderFactorsB95% CI for exp (β)tP
LowerUpper
Physical well-being
Female ( n= 193)
7 th chemotherapy0.0040.0010.0072.5140.013
Temporary job−0.024−0.045−0.004−2.3850.018
Male ( n= 159)
6 th chemotherapy0.0150.0030.0282.3960.018
Social well-being
Female ( n= 193)
Fluorouracil-based therapy−0.009−0.013−0.004−3.7280.0001
2 nd chemotherapy−0.007−0.012−0.002−2.9980.003
Urinary cancer−0.016−0.027−0.004−2.6790.008
Male ( n= 159)
2 nd chemotherapy−0.008−0.012−0.004−4.2740.0001
Urinary cancer0.0080.0020.0132.8180.005
Student0.0200.0090.0313.6230.0001
Taxane-based therapy0.0060.00010.0121.9120.058
Lymphoma0.0070.0000.0142.0070.047
Psychological well-being
Female ( n= 193)
Single0.4180.3390.49710.4250.0001
Retired−0.192−0.348−0.036−2.4210.016
Farmer−0.475−0.911−0.039−2.1470.033
Male ( n= 159)
Married−0.548−0.637−0.45912.1400.0001
Sarcoma−0.255−0.3980.113−3.5320.001
Student−0.281−0.468−0.094−2.9630.004
General well-being
Female ( n= 193)
Married0.412−0.494−0.33110.0150.0001
Retired−0.180−0.340−0.019−2.2120.028
Farmer−0.4910.939−0.044−2.1660.032
Multiple myeloma−0.1740.344−0.004−2.0180.045
Male ( n= 159)
Married0.5260.4350.61711.4050.0001
Sarcoma−0.235−0.381−0.089−3.1780.002
Student−0.224−0.415−0.033−2.3150.022

Discussion

We found that women had worse PhWB and SoWB than men. Gender did not affect PsWB and quality of life ( P > 0.05) [Tables 1 and 4 ]. The reason why women had lower PhWB and SoWB might be because of their physical weakness and delicacy. Some previous studies reported that woman had lower physical, social[ 27 ] and psychological[ 28 , 29 ] life qualities while Güner et al .[ 30 ] stated, on the contrary, that men had lower quality of life. Meantime, in some studies, gender did not affect the quality of life of the patients.[ 31 , 32 , 33 , 34 ]

Single patients in this study had worse PsWB and general well-being than married ones. Marital status did not affect PhWB and SoWB [Tables 1 and 4 ]. Previous studies indicated that married patients had higher quality of life and more family/friends.[ 11 , 35 ] Armstrong et al .[ 31 ] and Lis et al .[ 33 ] indicated, on the other hand, that marital status did not influence quality of life, but that social support improved the quality of life.[ 10 ] General well-being of married patients’ might be because of their higher social supports than those of single ones’.

Education in our study did not affect the quality of life of the patients [ Table 1 ]. Lis et al .[ 33 ] and Yıldız et al .[ 34 ] reported the same results. Knight et al .[ 36 ] found that lower education levels in urinary cancer patients had worse physical, social and role functions and experienced more side-effects. Can et al .[ 27 ] observed that university graduates had higher life levels than others. Güner et al .[ 30 ] similarly reported that the quality of life worsened when the education level was low.

Housewives had worse PhWB and SoWB than labors and clerks [ Table 1 ]. Can et al .[ 37 ] also reported that housewives had worse PsWB, PhWB and SoWB than other occupations. Timperi et al .[ 12 ] similarly found that working women with breast cancer had better PhWB, SoWB and PsWB. Those previous studies supported our findings. The lower life levels of housewives might be because of their distance from social life and their lesser social support. Government clerks had worse PsWB and general well-being than other professions [ Table 1 ]. The lower life levels of clerks might be because of their odd life perception.

We found that patients with operation, radiotherapy and chemotherapy had worse SoWB than those with chemotherapy or operation + chemotherapy. Therapy did not affect PhWB, PsWB and general well-being. Higher number of chemotherapies lowered the quality of life [Tables 2 and 4 ]. Similarly, Işıkhan et al .[ 38 ] did not find any relationship between disease period and quality of life ( n = 508). On the other hand, Arslan and Bölükbaşı[ 35 ] reported that operated patients had better life qualities. Can et al .[ 37 ] stated that later diagnosis lowered the quality of life. Similarly, Kwan et al .[ 39 ] indicated that increased therapy time decreased the quality of life and worsened physical and social functions. Longer medical therapy inhibits social life whereas diverse therapy types increase unwanted symptoms and, therefore, decreases energy and desire and, finally, lower SoWB. Therefore, it is most likely expected that operation, radiotherapy and chemotherapy worsen SoWB.

There was a relationship between medical diagnosis of patients and SoWB. Breast cancer patients had the worst SoWB. The other three cancers with worse SoWB were head–neck, sarcoma and gynecologic cancers. Colorectal cancer patients had the best SoWB. Cancer types in our study did not affect PhWB, PsWB and general well-being [Tables 2 and 4 ]. Can et al .[ 27 ] found that patients with breast, gynecologic and soft tissue cancers had worse SoWBs. Lis et al .[ 33 ] found that colorectal cancer patients had the best quality of life while lung cancer patients had the worst. Breast cancer patients were highly depressed[ 3 ] and, therefore, experienced worsened social relationships, changes in role performances and lowered life qualities.[ 4 ] Side-effects because of breast cancer caused hair loss, changed the body image, decreased sexual functions and libido and lowered social life quality due to early menopause.[ 5 ] Head-neck and sarcoma patients might have been affected by worsened body changes by the diseases and gynecologic cancer patients had negative effects on the role of women.

Taxane-based therapy induced statistically worse SoWB than those taking platinum- and doxorubicin- and fluorouracil-based therapies [Tables 2 and 4 ]. Can et al .[ 27 ] similarly found that taxane-based patients had worse SoWB than those taking platinum-, doxorubicin- and fluorouracil-based therapies. Taxane induced hair losses in 80% of the patients.[ 40 ] Patients had worse life qualities after 6 months of paclitaxel and platinum therapy, but not from lower doses of etoposide and cisplatin.[ 41 ]

Complementary therapy did not affect patients’ quality of life [ Table 3 ]. Previous studies indicated, however, that complementary therapy had influenced patients’ quality of life. Lis et al .[ 33 ] determined that nutrition supplements did not affect life quality in lung cancers, induced better life quality in colorectal cancer and higher PhWB and PsWB in breast cancers. Armstrong et al .[ 31 ] reported that complementary therapy did not affect the quality of life, while Wyatt et al .[ 42 ] added that lower quality-of-life patients had practiced more of complementary therapies. Hlubocky et al .[ 43 ] pronounced that patients practiced complementary therapy had lower points for all life quality parameters (social, physical, psychological and general). Sawada et al .[ 44 ] found that acupuncture during chemotherapy induced a better quality of life in patients.

Blessings/prayers, vow and sacrifice, consulting local herbalists, religious people — hodja and “ocak,” amulet use and drinking holy waters did not affect the quality of life of the patients [ Table 3 ]. However, religious belief/behaviors of black Americans affected their ability to overcome anxiety[ 45 ] and blessings, first by women and then by the elderly in both genders eased the disease.[ 45 , 46 ]

Tomb visit worsened SoWB in patients and did not affect PhWB, PsWB and quality of life [ Table 3 ]. Lead pouring patients had worse PhWB and SoWB, while lead pouring did not affect PsWB and quality of life. Amulet practice caused worse SoWB, but did not affect PhWB, PsWB and quality of life [ Table 3 ]. Interestingly, Kishore et al .[ 47 ] found that 60% of patients considered amulet as one of the causes of cancer. Amulet practice might be because of patients’ perception that cancer was caused by a bad eye. Patients with bad SoWB might be trying one possible “therapy” after other to just expect a “benefit.”

Cultural and religious rituals[ 15 ] were common among depressed women; 35% of patients consulted religious men for depression (Pir/Faqır), 27% believed in therapy of religious men and/or used amulets (15.3%) and 12% of the patients consumed holy water and plants. Cancer patients had more religious practices than non-cancer individuals, and these practices decreased depression symptoms.[ 14 ] African-American patients with breast cancer ( n = 147), who depended on God for their problems and believed that cure and the disease were desires of God had less worries.[ 48 ] Religion might have affected individuals’ quality of life under these disease conditions.

Can et al .[ 27 ] told that patients practicing more religious rituals were of lower life quality and had more psychological and social problems. Hamilton et al .[ 49 ] determined that patients who practiced religious ritual levels of perceived control about illness were higher. Similarly, Tarakeshwar et al .[ 18 ] stated that patients positive for religion had better quality of life than those negative for the same.

Limitations

This study was a restricted one because it was cross-sectional in nature and was applied in one center; therefore, the results could only be applied in the population studied in this center.

Footnotes

Source of Support: Nil.

Conflict of Interest: None declared.

References

1. American Cancer Society. Cancer Facts & Figures 2013. American Cancer Society, Atlanta. 2013

2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidance and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403. doi: 10.1016/j.ejca.2012.12.027.

3. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ. 2005;330:702–5. doi: 10.1136/bmj.38343.670868.D3.

4. Reich M, Lesur A, Pedrizet-Chevallier C. Depression, quality of life and breast cancer: A review of the literature. Breast Cancer Res Treat. 2008;110:9–17. doi: 10.1007/s10549-007-9706-5.

5. Shapiro SL, Lopez AM, Schwart GE, Bootzin R, Fiqueredo AJ, Braden CJ, et al. Quality of life and breast cancer relationships to psychosocial variables. J Clin Psychol. 2001;57:501–19. doi: 10.1002/jclp.1026.

6. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early stage breast cancer. J Clin Oncol. 1998;16:1380–7. doi: 10.1200/JCO.1998.16.4.1380.

7. Webster K, Cella D. Quality of life in patients with low-grade non-Hodgkin's lymphoma. Oncology. 1998;12:697–714.

8. Kurt AS, Çetinkaya S. Lösemili çocuklarda yaşam kalitesi ve hemşirelik bakımı (Life quality in children with leukaemia and nursing care) Fırat Sağlık Hizmetleri Dergisi. 2008;3:35–55.

9. Rodrigues AM. Determinants of Overall Quality Of Life in People with Advanced Cancer. Dissertation, Mcgill University of Canada. 2012

10. Eom CS, Shin DW, Kim SY, Yang HK, Jo HS, Kweon SS, et al. Impact of perceived social support on the mental health and health-related quality of life in cancer patients: Results from a nationwide, multicenter survey in South Korea. Psychooncology. 2013;22:1283–90. doi: 10.1002/pon.3133.

11. Miller RC, Atherton PJ, Kabat FB, Fredericksen MB, Geno DM, Deschamps C, et al. Marital status and quality of life in patients with esophageal cancer or barrett's esophagus: The mayo clinic esophageal adenocarcinoma and barrett's esophagus registry study. Dig Dis Sci. 2010;55:2860–8. doi: 10.1007/s10620-009-1100-1.

12. Timperi AV, Ergas IJ, Rehkopf DH, Roh JM, Kwan ML, Kushi LH. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013;22:1411–20. doi: 10.1002/pon.3157.

13. Paltiel O, Avitzou M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, et al. Determinants of the use of complementary therapies by patient with cancer. J Clin Oncol. 2001;19:2439–48. doi: 10.1200/JCO.2001.19.9.2439.

14. Musick MA, Koenig HG, Hays JC, Cohen HJ. Religious activity and depression among community-dwelling elderly persons with cancer: The moderating effect of race. J Gerontol B Psychol Sci Soc Sci. 1998;53:218–27. doi: 10.1093/geronb/53b.4.s218.

15. Nisar N, Billoo N, Gadit AA. Prevalence of depression and the associated risk factors among adult women in a fishing community. J Pak Med Assoc. 2004;54:519–25.

16. Pargament KI. New York: Guilford Press; 1997. The Psychology of Religion and Coping: Theory, Research, Practice.

17. Ahmadi F. Sweden: Elanders Gotab, Stockholm; 2006. Culture, Religion and Spirituality in Coping. The Example of Cancer Patients in Sweden.

18. Tarakeshwar N, Vanderwerker LC, Paulk E, Pearce MJ, Kasl SV, Prigerson HG. Religious coping is associated with the quality of life of patients with advanced cancer. J Palliat Med. 2006;9:646–57. doi: 10.1089/jpm.2006.9.646.

19. Wicks JW. Bowling Green, Ohio: Population and Society Research Center; 1990. Greater Toledo Area Survey.

20. Can G, Aydıner A. Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey. Eur J Oncol Nurs. 2011;15:3–11. doi: 10.1016/j.ejon.2009.10.010.

21. Schag CC, Heinric RL, Ganz PA. Karnofsky Performance Status Revised: Reliability, Validity and Guidelines. J Clin Oncol. 1984;2:87–93. doi: 10.1200/JCO.1984.2.3.187.

22. Akyüz A, Dede M, Çetintürk A, Yavan T, Yenen MC, Sarici SU, et al. Self application of complementary and alternative medicine by patients with gynecologic cancer. Gynecol Obstet Invest. 2007;64:75–81. doi: 10.1159/000099634.

23. Fouladbakhsh JM, Stommel M. Gender, symptom experience and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum. 2010;37:E7–15. doi: 10.1188/10.ONF.E7-E15.

24. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: A European survey. Ann Oncol. 2005;16:655–63. doi: 10.1093/annonc/mdi110.

25. Nazik E, Nazik H, Api E, Kale A, Aksu M. Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pac J Cancer Prev. 2012;13:21–5. doi: 10.7314/apjcp.2012.13.1.021.

26. Uçan ö, Pehlivan S, Ovayolu N, Sevinc A, Camci C. The use of complementary therapies in cancer patients: A questionnaire-based descriptive survey from southeastern Turkey. Am J Clin Oncol. 2008;31:589–94. doi: 10.1097/COC.0b013e31817700cc.

27. Can G, Erol O, Aydıner A, Topuz E. Quality of life and complementary and alternative medicine use among cancer patients in Turkey. Eur J Oncol Nurs. 2009;13:287–94. doi: 10.1016/j.ejon.2009.03.007.

28. Polit DF, Beck CT. Essentials of Nursing Research (Sth.ed) London: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.

29. Pud D. Gender differences in predicting quality of life in cancer patients with pain. Eur J Oncol Nurs. 2011;15:486–91. doi: 10.1016/j.ejon.2010.12.005.

30. Güner P, Işıkhan V, Kömürcü S, Il S, Oztürk B, Arpaci F, et al. Quality of life and sociodemographic characteristics of patients with cancer in Turkey. Oncol Nurs Forum. 2006;33:1171–6. doi: 10.1188/06.ONF.1171-1176.

31. Armstrong T, Cohen MZ, Hess KR, Manning R, Lee EL, Tamayo G, et al. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manage. 2006;32:148–54. doi: 10.1016/j.jpainsymman.2006.02.015.

32. Cheng KK, Lee DT. Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol. 2011;78:127–37. doi: 10.1016/j.critrevonc.2010.03.002.

33. Lis CG, Cambron JA, Grutsch JF, Granick J, Grupda D. Self reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer. 2006;14:193–9. doi: 10.1007/s00520-005-0876-6.

34. Yıldız İ, Özgüroğlu M, Toptaş T, Turna H, Sen F, Yıldız M. Patterns of complementary and alternative medicine use among Turkish cancer patients. J Palliat Med. 2013;16:383–90. doi: 10.1089/jpm.2012.0226.

35. Arslan S, Bölükbaşı N. Evaluation of the life quality of the patients with cancer. Atatürk Üniversitesi Hemşirelik Yüksekokulu Dergisi. 2003;6:38–47.

36. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, et al. Education predicts quality of life among men with prostate cancer cared for in the department of veterans affairs. Cancer. 2007;109:1769–76. doi: 10.1002/cncr.22597.

37. Can G, Demir M, Aydıner A. Complementary therapies used by Turkish breast cancer patients undergoing chemotherapy. Breast Care. 2012;7:471–5. doi: 10.1159/000345462.

38. Işıkhan V, Güner P, Kömürcü Ş, Özat A, Arpacı F, Öztürk B. The relationship between disease features and quality of life in patients with cancer--I. Cancer Nurs. 2001;24:490–5. doi: 10.1097/00002820-200112000-00012.

39. Kwan IG, Ryu E, Noh GO, Sung YH. Health-related quality of life in cancer patients between baseline and a three-year follow up. Eur J Oncol Nurs. 2012;16:131–6. doi: 10.1016/j.ejon.2011.05.004.

40. Wang J, Lu Z, Au J. Protection against chemotherapy-induced alopecia. Pharm Res. 2006;23:2503–14. doi: 10.1007/s11095-006-9105-3.

41. Bonomi P, Kim K, Fairclough D, Cella D, Kugler J, Rowinsky E, et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus Etoposide with cisplatin: Result of an Eastern Cancer Cooperative Oncology Group Trial. J Clin Oncol. 2000;18:623–31. doi: 10.1200/JCO.2000.18.3.623.

42. Wyatt G, Sikorskii A, Wiills EC, Su H. Complementary and alternative medicine use, spending and quality of life in early stage breast cancer. Nurs Res. 2010;59:58–66. doi: 10.1097/NNR.0b013e3181c3bd26.

43. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase 1 trials: A study of prognosis, quality of life and preferences for decision making. J Clin Oncol. 2007;25:548–54. doi: 10.1200/JCO.2005.03.9800.

44. Sawada NO, Zago MM, Galvão CM, Cardozo FM, Zandonai AP, Okino L, et al. The outcomes of visualization and acupuncture on the quality of life of adult cancer patients receiving chemotherapy. Cancer Nurs. 2010;33:E21–8. doi: 10.1097/NCC.0b013e3181d86739.

45. Neighbors HW, Jackson JS, Bowman PJ, Gurin G. Stress, coping, and black mental health: Preliminary findings from a national study. Prev Hum Serv. 1983;2:5–29. doi: 10.1300/J293v02n03_02.

46. Bijur PE, Wallston KA, Smith CA, Lifrak S, Friedman SB. Gender differences in turning to religion for coping. Paper presented at the meeting of the American Psychological Association. Toronto. 1993

47. Kishore J, Ahmadi I, Kauri R, P K M. Beliefs perceptions about cancers among patients attending radiotherapy OPD in Delhi, India. Asian Pac J Cancer Prev. 2008;9:155–8.

48. Bowie J, Curbow B, Laveıst T, Fizgerald S, Pargament K. The relationship between religious coping style and anxiety over breast cancer in African American women. J Relig Health. 2001;40:411–22.

49. Hamilton AS, Miller MF, Arora NK, Bellizzi KM, Rowland JH. Predictors of use of complementary and alternative medicine by non-Hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther. 2013;12:225–35. doi: 10.1177/1534735412449733.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты